BLOG

Windtree Therapeutics Leverages Heart Failure Asset Istaroxime in Multiple Indications

Windtree Therapeutics Chief Executive Officer Craig Fraser called 2020 a transformative and productive year for the Bucks County company focused on the development of life-saving therapeutics for acute cardiovascular and pulmonary disorders.